AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 34309665
Drug: Experimental arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Experimental arm (bevacizumab administered 4 days before chemotherapy)
Trial: 33189161
Drug: SNG001 (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SNG001 (6 MIU) inhaled daily for 14 days
Trial: 33189161
Drug: Placebo inhaled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo inhaled daily for 14 days
Trial: 35998039
Drug: Nicotinamide Riboside
RxNorm normalized name: Nicotinamide riboside
DrugBank: Nicotinamide riboside (DB14933)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotinamide Riboside (1000 mg) + Pterostilbene (200 mg)
Trial: 33871071
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of topical and oral glutathione
Trial: 33871071
Drug: Topical glutathione
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical glutathione
Trial: 34247632
Drug: Standard prednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard prednisolone (1 mg/kg/day)
Trial: 34247632
Drug: Reduced prednisolone
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced prednisolone (0.5 mg/kg/day) and alfacalcidol (0.5 μg/day)
Trial: 33171595
Drug: Probiotic plus
RxNorm normalized name: CVS Advanced Probiotic Plus Fiber Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic plus biotin treatment
Trial: 36789614
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant
Trial: 36801466
Drug: Sirolimus therapy
RxNorm normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Sirolimus therapy
Trial: 36709533
Drug: Agalsidase beta
RxNorm normalized name: Agalsidase beta
DrugBank: Agalsidase beta (DB00103)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Agalsidase beta treatment
Trial: 37460214
Drug: Longer time
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Longer time to treatment
Trial: 37378404
Drug: Ambrisentan treatment
RxNorm normalized name: Ambrisentan
DrugBank: Ambrisentan (DB06403)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ambrisentan treatment
Trial: 33410093
Drug: Biphasic insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Biphasic insulin aspart 30/70 (BIAsp 30)
Trial: 36301572
Drug: Olaparib (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olaparib (200 mg twice daily)
Trial: 33517185
Drug: Imatinib discontinuation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib discontinuation
Trial: 33483802
Drug: Intravenous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous ketamine infusion
Trial: 38913933
Drug: Standard neoadjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard neoadjuvant chemotherapy
Trial: 34120312
Drug: Dacomitinib 45
RxNorm normalized name: dacomitinib 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dacomitinib 45 mg QD
Trial: 39014980
Drug: Disengagement coping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disengagement coping (e.g., avoidance)
Trial: 32858478
Drug: Prenatal exposure
RxNorm normalized name: Ardisia crenata root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenatal exposure to chemotherapy
Trial: 38484432
Drug: Bosutinib 500
RxNorm normalized name: bosutinib 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bosutinib 500 mg once daily
Trial: 37368512
Drug: Lower insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lower insulin sensitivity
Trial: 37295336
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone Replacement Therapy (GHRT)
Trial: 39691290
Drug: DAA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAA treatment
Trial: 34748572
Drug: Nifurtimox-eflornithine combination
RxNorm normalized name: nifurtimox
DrugBank: Nifurtimox (DB11820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifurtimox-eflornithine combination therapy (NECT)
Trial: 34015791
Drug: Focal Electrically
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focal Electrically Administered Seizure Therapy (FEAST)
Trial: 32453640
Drug: DA-EPOCH-R therapy
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DA-EPOCH-R therapy
Trial: 33470063
Drug: Niraparib 300
RxNorm normalized name: niraparib 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niraparib 300 mg/day
Trial: 35075289
Drug: Lentiviral gene
RxNorm normalized name: Immature cell growth-inhibiting gene 1 protein
DrugBank: Cerliponase alfa (DB13173)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Lentiviral gene therapy
Trial: 39552592
Drug: Calcium Channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium Channel Blockers
Trial: 39773004
Drug: Subcutaneous (SC)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (SC) rituximab
Trial: 39773004
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) rituximab
Trial: 38332651
Drug: Hydroxyurea at
RxNorm normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyurea at maximum tolerated dose (MTD)
Trial: 36146760
Drug: Direct-acting antivirals
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct-acting antivirals (DAAs)
Trial: 37246348
Drug: Blinatumomab treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blinatumomab treatment
Trial: 39005691
Drug: Debulking chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Debulking chemotherapy
Trial: 34078259
Drug: OnabotulinumtoxinA treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OnabotulinumtoxinA treatment
Trial: 32192746
Drug: Dual antiplatelet
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual antiplatelet therapy (DAPT) at 2 years
Trial: 33139350
Drug: Laronidase enzyme
RxNorm normalized name: Laronidase
DrugBank: Laronidase (DB00090)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Laronidase enzyme replacement therapy (ERT)
Trial: 36166340
Drug: Triple antithrombotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple antithrombotic therapy
Trial: 34238024
Drug: Subcutaneous adipose
RxNorm normalized name: human adipose preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous adipose tissue (SAT)
Trial: 37295810
Drug: Pipeline Embolization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pipeline Embolization Device (PED) treatment
Trial: 36301338
Drug: Daratumumab 8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daratumumab 8 mg/kg
Trial: 32532858
Drug: WEB treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WEB treatment
Trial: 37141294
Drug: pembrolizumab 2
RxNorm normalized name: pembrolizumab 25 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pembrolizumab 2 mg/kg
Trial: 34863270
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of therapies
Trial: 34800495
Drug: Morphine consumption
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine consumption
Trial: 39441901
Drug: Ibrutinib therapy
RxNorm normalized name: Ibrutinib
DrugBank: Ibrutinib (DB09053)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ibrutinib therapy
Trial: 33932130
Drug: Dabrafenib 150
RxNorm normalized name: Dabrafenib
DrugBank: Dabrafenib (DB08912)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Dabrafenib 150 mg twice daily
Trial: 38446574
Drug: Gene therapy
RxNorm normalized name: E1A gene therapy
DrugBank: RGG0853 (DB18669)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gene therapy (GT)
Trial: 38421404
Drug: Venetoclax monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venetoclax monotherapy
Trial: 33630063
Drug: Sipuleucel-T treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sipuleucel-T treatment
Trial: 37722087
Drug: CC-115
RxNorm normalized name: CC-115
DrugBank: CC-115 (DB12740)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC-115
Trial: 37358640
Drug: Idelalisib therapy
RxNorm normalized name: Idelalisib
DrugBank: Idelalisib (DB09054)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Idelalisib therapy
Trial: 36548028
Drug: Digital Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digital Medicine System (DMS)
Trial: 39158832
Drug: Per-oral endoscopic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Per-oral endoscopic myotomy (POEM)
Trial: 37316692
Drug: Osimertinib 80
RxNorm normalized name: osimertinib 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osimertinib 80 mg orally once daily
Trial: 36958766
Drug: Tofacitinib 5
RxNorm normalized name: tofacitinib 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 5 mg two times per day
Trial: 36958766
Drug: Tofacitinib 10
RxNorm normalized name: tofacitinib 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 10 mg two times per day
Trial: 37955849
Drug: Hybrid closed-loop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hybrid closed-loop (HCL) insulin delivery system
Trial: 35291351
Drug: Metreleptin therapy
RxNorm normalized name: Metreleptin
DrugBank: Metreleptin (DB09046)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metreleptin therapy
Trial: 35846221
Drug: CC-122
RxNorm normalized name: CC
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CC-122
Trial: 39290861
Drug: Disease-modifying therapies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease-modifying therapies (DMTs)
Trial: 32320048
Drug: Pembrolizumab (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pembrolizumab (10 mg/kg every 2 weeks for up to 2 years)
Trial: 33404519
Drug: 0.5 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/day entecavir
Trial: 39555240
Drug: Immune checkpoint
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immune checkpoint inhibitor therapy
Trial: 33359404
Drug: Avelumab 10
RxNorm normalized name: Avelumab
DrugBank: Avelumab (DB11945)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Avelumab 10 mg/kg
Trial: 37848867
Drug: Long-term antiretroviral
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term antiretroviral therapy (ART)
Trial: 32427579
Drug: Atezolizumab (anti-PD-L1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atezolizumab (anti-PD-L1 therapy)
Trial: 35164991
Drug: MenB-FHbp vaccine
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MenB-FHbp vaccine
Trial: 32224030
Drug: Glycoprotein IIb/IIIa
RxNorm normalized name: GLYCOPROTEIN IIB/IIIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycoprotein IIb/IIIa inhibitors (GPIs)
Trial: 37331992
Drug: Tofacitinib 5
RxNorm normalized name: tofacitinib 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib 5 or 10 mg BID
Trial: 38335386
Drug: Integrative Korean
RxNorm normalized name: Korean ginseng root
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrative Korean medicine treatment
Trial: 35929414
Drug: EGFR tyrosine
RxNorm normalized name: Tyrosine
DrugBank: Tyrosine (DB00135)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EGFR tyrosine kinase inhibitors (EGFR-TKIs)
Trial: 32534242
Drug: Dabrafenib 150
RxNorm normalized name: Dabrafenib
DrugBank: Dabrafenib (DB08912)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Dabrafenib 150 mg twice daily and trametinib 2 mg once daily
Trial: 36599698
Drug: Serum NF-L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum NF-L
Trial: 38828959
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg osimertinib once daily
Trial: 37273449
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules for six months
Trial: 35677318
Drug: Cabazitaxel 20
RxNorm normalized name: cabazitaxel 20 mg/mL intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabazitaxel 20 mg/m²
Trial: 37940142
Drug: Live zoster
RxNorm normalized name: Varicella zoster vaccine (live/attenuated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live zoster vaccine
Trial: 35026142
Drug: Sofosbuvir (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir (400 mg) and velpatasvir (100 mg) once daily for 12 weeks
Trial: 37261654
Drug: Adjuvant endocrine
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant endocrine therapy (AET)
Trial: 38885481
Drug: CD19 CAR
RxNorm normalized name: CAR.CD19-Redirected T cells
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CD19 CAR T-cell therapy
Trial: 39239186
Drug: High-flow nasal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-flow nasal oxygen (HFNO) therapy
Trial: 36000434
Drug: LDL-C <70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDL-C <70 mg/dL
Trial: 39181168
Drug: Direct-acting antiviral
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct-acting antiviral agents
Trial: 32318647
Drug: MLE4901 (NK3R
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MLE4901 (NK3R antagonist)
Trial: 34506666
Drug: Icatibant treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Icatibant treatment
Trial: 36093129
Drug: Non-vitamin K
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-vitamin K antagonist oral anticoagulants (NOACs)
Trial: 38467716
Drug: Cochleural Alternating
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cochleural Alternating Acoustic Beam Therapy (CAABT)
Trial: 34515993
Drug: Adjuvant S-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant S-1 chemotherapy
Trial: 35483358
Drug: EGFR inhibitors
RxNorm normalized name: Egfr t790m inhibitor pf-06747775
DrugBank: Mavelertinib (DB16228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGFR inhibitors
Trial: 34255353
Drug: Decitabine 20
RxNorm normalized name: Decitabine
DrugBank: Decitabine (DB01262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Decitabine 20 mg/m²
Trial: 39123434
Drug: TPF induction
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPF induction chemotherapy (docetaxel, cisplatin, and 5-fluorouracil)
Trial: 32000408
Drug: Interventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interventional treatment
Trial: 36696843
Drug: Treatment type
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment type
Trial: 38330380
Drug: Concurrent chemoradiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiation therapy (CCRT)
Trial: 37276084
Drug: Behavioral activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral activation therapy (BA)
Trial: 37890960
Drug: Xylitol syrup
RxNorm normalized name: Xylitol
DrugBank: Xylitol (DB11195)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Xylitol syrup
Trial: 33761887
Drug: Beliefs about
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beliefs about medications
Trial: 34622233
Drug: Tocilizumab (IL-6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab (IL-6 receptor antibody)
Trial: 35362522
Drug: Direct-acting antiviral
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct-acting antiviral therapy
Trial: 36063832
Drug: Azacitidine 75
RxNorm normalized name: Azacitidine
DrugBank: Azacitidine (DB00928)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Azacitidine 75 mg/m²
Trial: 39012226
Drug: Control group,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group, treatment not specified
Trial: 38010394
Drug: Talazoparib (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Talazoparib (1 mg/day)
Trial: 35773640
Drug: Rehabilitation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation treatment
Trial: 35926961
Drug: Biological prosthesis
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological prosthesis
Trial: 33961488
Drug: Lenvatinib 24
RxNorm normalized name: lenvatinib 24 MG Daily Dose 30 Day Supply Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lenvatinib 24 mg once daily
Trial: 34660853
Drug: Burosumab treatment
RxNorm normalized name: Burosumab
DrugBank: Burosumab (DB14012)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Burosumab treatment
Trial: 32649919
Drug: Low-dose chest
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose chest CT (LDCT) screening
Trial: 38049621
Drug: Nonavalent vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonavalent vaccine
Trial: 33836153
Drug: Treatment-related death
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-related death
Trial: 36130508
Drug: Anti-PD-1 treatment
RxNorm normalized name: Dianeal PD-2/1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-PD-1 treatment
Trial: 32430709
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g OGTT
Trial: 32430709
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g OGTT
Trial: 34973207
Drug: Etonogestrel implants
RxNorm normalized name: etonogestrel Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etonogestrel implants
Trial: 38135371
Drug: Intravenous decitabine
RxNorm normalized name: Decitabine
DrugBank: Decitabine (DB01262)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous decitabine
Trial: 35588166
Drug: Broad-spectrum antibiotics
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broad-spectrum antibiotics (AB+)
Trial: 36348206
Drug: Cytoreductive surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)
Trial: 36656302
Drug: Osimertinib treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osimertinib treatment
Trial: 32107887
Drug: Analytical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analytical treatment interruption (ATI)
Trial: 32277401
Drug: Dulaglutide (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dulaglutide (both doses)
Trial: 33770805
Drug: OnabotulinumtoxinA injection
RxNorm normalized name: onabotulinumtoxinA Injection
DrugBank: Botulinum toxin type A (DB00083)
FDA approved: no
EMA approved: yes
PMDA approved: yes
Description: OnabotulinumtoxinA injection (100 units)
Trial: 37889487
Drug: Daily Calorie
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily Calorie Restriction (CR)
Trial: 39132335
Drug: One-month dual
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-month dual antiplatelet therapy (DAPT)
Trial: 33638263
Drug: Treatment-naïve patients
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-naïve patients
Trial: 34152395
Drug: Zanubrutinib 320
RxNorm normalized name: Zanubrutinib
DrugBank: Zanubrutinib (DB15035)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zanubrutinib 320 mg once daily
Trial: 32171470
Drug: Androgen-deprivation therapies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androgen-deprivation therapies (ADTs)
Trial: 33435412
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group not specified; details on control treatment not available.
Trial: 33251753
Drug: Telephone-based cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-based cognitive behavioural therapy (Tele-CBT)
Trial: 36513815
Drug: Pressurized intraperitoneal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pressurized intraperitoneal aerosol chemotherapy (PIPAC)
Trial: 34094549
Drug: Low-dose interleukin-2
RxNorm normalized name: Interleukin-2 aldesleukin
DrugBank: Aldesleukin (DB00041)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-dose interleukin-2 (IL-2) therapy
Trial: 32428369
Drug: Susceptibility-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Susceptibility-guided therapy